BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28455144)

  • 1. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
    Xia P; Huang M; Zhang Y; Xiong X; Yan M; Xiong X; Yu W; Song E
    Gynecol Oncol; 2019 Feb; 152(2):387-395. PubMed ID: 30442385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.
    He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X
    Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
    Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
    Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.
    Wang X; Zhang Y; Zhao Y; Liang Y; Xiang C; Zhou H; Zhang H; Zhang Q; Qing H; Jiang B; Xiong H; Peng L
    Oncotarget; 2016 Aug; 7(34):55663-55676. PubMed ID: 27494878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
    Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
    Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
    Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
    J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
    Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
    Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.
    Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F
    Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.